Search for topics, articles, videos, research, etc...
Hit enter to search or ESC to close
Are you looking for:
Research News
Donate Now
Parkinson's Research

Research News

Read the latest developments, reporting and analysis from the world of Parkinson's research, including progress made in studies, tools and collaborations funded by The Michael J. Fox Foundation.
  • Scientist in lab holding up blood sample

    What We Fund: $40.2M Toward Tools to Measure Parkinson’s and Therapies to Treat It

    The Michael J. Fox Foundation (MJFF) announces 129 grants that total more than $40.2 million awarded in August and September 2024.
    Learn more
  • Patient on bed speaking to a doctor

    FDA Approves New Infusion-based Treatment for Parkinson’s

    The U.S. Food and Drug Administration has approved Vyalev, the first under-the-skin levodopa/carbidopa infusion for Parkinson’s disease. Learn more.
    Learn more
  • Research Podcast Cover

    Episode 25: Creating Alpha-Synuclein Cell Lines and Supporting Open Science with Birgitt Schüle

    Dr. Birgitt Schüle discusses her work developing alpha-synuclein cell lines, challenges and opportunities in the field, and important considerations surrounding open science.
    Learn more
  • Promoting diversity in Parkinson's research benefits every one

    Research Paper Adds Clinical Anchors to Proposed Parkinson’s Staging System

    Researchers propose adding clinical anchors to the Parkinson’s disease research framework called the Neuronal alpha-Synuclein Disease Integrated Staging System.
    Learn more
  • diversity clinical research.jpg

    Keeping a Focus on Diversity in Parkinson’s Research

    The Michael J. Fox Foundation is working toward a world without Parkinson’s disease, and diversity in research can unlock key mysteries to help us get there.
    Learn more
  • Charting the Genetics of Parkinson's Disease

    MJFF launches program to expedite development of LRRK2-targeted therapies and biomarkers for Parkinson’s disease

    The Michael J. Fox Foundation is embarking on a major new initiative to rapidly expedite development of therapeutic strategies targeting LRRK2.
    Learn more
  • Research Podcast Cover

    Episode 24: Developing FLEXISyn to Identify and Measure Changes in Alpha-Synuclein in Parkinson's Disease with Judith Steen

    Dr. Judith Steen discusses her work creating novel qualitative and quantitative tools and workflows at the interface of proteomics and transcriptomics, including their novel FLEXI platform.
    Learn more
Close-up portrait

Join the Study that's Changing Everything

The Parkinson's Progression Markers Initiative is changing how patients, families, doctors and scientists think about brain disease. Now it needs you.

Get Started
Michael J. Fox in blue sweater posing for the camera.

Patients First

Our Foundation exists for one reason: to speed breakthroughs patients can feel in their everyday lives.

Read Our Promise
"The question most frequently asked of us is: 'How close are we to a cure for Parkinson’s disease?' With over $800 million in Parkinson's research funded to date, the simplest answer is: closer than ever."
Todd Sherer, PhD
Todd Sherer, PhD Chief Mission Officer
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.